Ministers to end Palantir’s contract with NHS in England in 2029

by | Nov 18, 2026 | Health

Ministers to end Palantir’s contract with NHS in England in 2029

The Department of Health and Social Care announced it will terminate its relationship with Palantir, the US technology company providing the NHS’s federated data platform, by 2029. Rather than exercising a contractual break clause available next spring, officials opted to extend the arrangement for two additional years to facilitate the transition to domestically-based suppliers.

Health Minister James Frith stated the decision aims to enhance public confidence in NHS technology systems, reduce reliance on a single vendor, and enable British firms to assume responsibility for critical digital infrastructure. The DHSC indicated it will launch a procurement process to identify UK technology companies capable of assuming Palantir’s current role.

The announcement faced criticism from opposition lawmakers and civil society organizations. Chi Onwurah, chair of the Commons science and technology select committee, expressed disappointment that the government declined to activate the contractual break clause available in 2027. Liberal Democrat MP Martin Wrigley characterized the extended timeline as a delay, noting that the arrangement keeps Palantir—co-founded by US political figure Peter Thiel—in control of NHS health data for several additional years. Human rights organizations including Amnesty International and Just Treatment had urged the government to terminate the contract earlier, citing concerns about Palantir’s work with other entities.

Adoption of Palantir’s federated data platform has remained limited across the NHS. Following revelations that only 29 of approximately 137 trusts initially cited as beneficiaries were actively using the system, NHS England removed claims about broader adoption from its public materials. Many healthcare professionals have expressed skepticism regarding the platform’s effectiveness and benefits.

Some Labour MPs welcomed the decision to end single-supplier dependence, while emphasizing the importance of ensuring continuity of patient care throughout the transition process.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI